As of May 22
| +1.19 / +0.98%|
The 6 analysts offering 12-month price forecasts for Madrigal Pharmaceuticals Inc have a median target of 165.50, with a high estimate of 210.00 and a low estimate of 130.00. The median estimate represents a +34.42% increase from the last price of 123.12.
The current consensus among 7 polled investment analysts is to Buy stock in Madrigal Pharmaceuticals Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.